Year archive

Ananda Pharma Plc — 2025 filings

All 38 regulatory filings released by Ananda Pharma Plc (ANAN) in 2025, sourced directly from the official regulator.

38 Filings

2025 Period

2025 filings (38)

Filing	Released	Lang
US Cannabis Rescheduling Regulatory Filings	2025-12-19	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2025-12-12	English
Redemption of Unsecured CLNs and Director Dealing Director's Dealing	2025-12-03	English
CIPN Ethics Approval Legal Proceedings Report	2025-12-03	English
Initial Data from Phase 1 Study Legal Proceedings Report	2025-11-27	English
Posting of Q&A Delisting Announcement	2025-11-26	English
Notice of General Meeting and Proposed Delisting Delisting Announcement	2025-11-24	English
Confirmation of receipt of £168k R&D tax refund Regulatory Filings	2025-11-10	English
Interims for the six months ended 31 July 2025 Interim / Quarterly Report H1 2025	2025-10-13	English
Ananda Hits Key Phase 1 Milestone for MRX1 CBD Regulatory Filings	2025-10-06	English
Ananda ends UCL/GOSH trials, prioritises MRX1 Regulatory Filings	2025-09-26	English
Ananda attending Cannabinoid Summit Regulatory Filings	2025-09-16	English
Ananda to attend Science in the City Regulatory Filings	2025-09-01	English
Result of Annual General Meeting Declaration of Voting Results & Voting Rights Announcements	2025-08-26	English
Webinar Presentation Release Report Publication Announcement	2025-08-19	English
Notice of Annual General Meeting AGM Information	2025-07-30	English
Publication of Annual Report Audit Report / Information FY 2025	2025-07-30	English
First Participant Dosed in MRX1 CBD Phase 1 Study Regulatory Filings	2025-07-15	English
MRX1 Delivered to Clinical Trial Site Regulatory Filings	2025-07-01	English
Key Milestone in MRX1 Path to Clinical Trials Regulatory Filings	2025-06-23	English
Publication of Phase 1 study on clinicaltrials.gov Regulatory Filings	2025-06-03	English
MRX1 achieves 2 years of stability data Regulatory Filings	2025-06-02	English
Ananda to attend Benzinga Conference Regulatory Filings	2025-05-27	English
Appointment of Giles Moss as Advisor Regulatory Filings	2025-05-06	English
TGA Receives Ananda’s Clinical Trial Notification Regulatory Filings	2025-04-28	English
Ananda Pharma commences trading on OTCQB Exchange Regulatory Filings	2025-04-14	English
Appointment of Chris Tovey, GW Pharma Former COO Regulatory Filings	2025-04-08	English
MRX1 Granted Ethics Approval for Phase 1 Study Regulatory Filings	2025-04-02	English
Master Investor Conference Attendance Regulatory Filings	2025-03-12	English
Director/PDMR Shareholding Director's Dealing	2025-03-04	English
CEO Presenting at Private Investor Conference Regulatory Filings	2025-02-21	English
Achievement of Manufacturing Milestone for MRX1 Regulatory Filings	2025-02-20	English
Director/PDMR Shareholding Director's Dealing	2025-02-06	English
Appointment of Commercial Adviser Board/Management Information	2025-02-06	English
Change of Registered Office Regulatory Filings	2025-02-03	English
Ananda Pharma Appoints Viridian Capital Advisors Regulatory Filings	2025-02-03	English
2025 Kick-Off Webinar Regulatory Filings	2025-01-22	English
Total Voting Rights Regulatory Filings	2025-01-07	English